127 related articles for article (PubMed ID: 25657009)
1. MicroRNA-214 suppresses gluconeogenesis by targeting activating transcriptional factor 4.
Li K; Zhang J; Yu J; Liu B; Guo Y; Deng J; Chen S; Wang C; Guo F
J Biol Chem; 2015 Mar; 290(13):8185-95. PubMed ID: 25657009
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-721 regulates gluconeogenesis via KDM2A-mediated epigenetic modulation in diet-induced insulin resistance in C57BL/6J mice.
Kabeer SW; Sharma S; Sriramdasu S; Tikoo K
Biol Res; 2024 May; 57(1):27. PubMed ID: 38745315
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA Gomafu upregulates Foxo1 expression to promote hepatic insulin resistance by sponging miR-139-5p.
Yan C; Li J; Feng S; Li Y; Tan L
Cell Death Dis; 2018 Feb; 9(3):289. PubMed ID: 29459686
[TBL] [Abstract][Full Text] [Related]
4. TOX3 deficiency mitigates hyperglycemia by suppressing hepatic gluconeogenesis through FoxO1.
Liu C; Zheng Y; Hu S; Liang X; Li Y; Yu Z; Liu Y; Bian Y; Man Y; Zhao S; Liu X; Liu H; Huang T; Ma J; Chen ZJ; Zhao H; Zhang Y
Metabolism; 2024 Mar; 152():155766. PubMed ID: 38145825
[TBL] [Abstract][Full Text] [Related]
5. Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids.
Martino MR; Gutiérrez-Aguilar M; Yiew NKH; Lutkewitte AJ; Singer JM; McCommis KS; Ferguson D; Liss KHH; Yoshino J; Renkemeyer MK; Smith GI; Cho K; Fletcher JA; Klein S; Patti GJ; Burgess SC; Finck BN
Cell Rep; 2022 Nov; 41(7):111633. PubMed ID: 36384117
[No Abstract] [Full Text] [Related]
6. Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies.
Zhu H; Leung SW
Diabetologia; 2015 May; 58(5):900-11. PubMed ID: 25677225
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-185 targets SOCS3 to inhibit beta-cell dysfunction in diabetes.
Bao L; Fu X; Si M; Wang Y; Ma R; Ren X; Lv H
PLoS One; 2015; 10(2):e0116067. PubMed ID: 25658748
[TBL] [Abstract][Full Text] [Related]
8. Drosophila melanogaster activating transcription factor 4 regulates glycolysis during endoplasmic reticulum stress.
Lee JE; Oney M; Frizzell K; Phadnis N; Hollien J
G3 (Bethesda); 2015 Feb; 5(4):667-75. PubMed ID: 25681259
[TBL] [Abstract][Full Text] [Related]
9. microRNA-21 mediates epithelial-mesenchymal transition of human hepatocytes via PTEN/Akt pathway.
Liu Z; Wang J; Guo C; Fan X
Biomed Pharmacother; 2015 Feb; 69():24-8. PubMed ID: 25661333
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1.
Phatak P; Byrnes KA; Mansour D; Liu L; Cao S; Li R; Rao JN; Turner DJ; Wang JY; Donahue JM
Oncogene; 2016 Apr; 35(16):2087-97. PubMed ID: 26234674
[TBL] [Abstract][Full Text] [Related]
11. miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway.
Zhao C; Sun W; Zhang P; Ling S; Li Y; Zhao D; Peng J; Wang A; Li Q; Song J; Wang C; Xu X; Xu Z; Zhong G; Han B; Chang YZ; Li Y
RNA Biol; 2015; 12(3):343-53. PubMed ID: 25826666
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA regulatory networks in human adipose tissue and obesity.
Arner P; Kulyté A
Nat Rev Endocrinol; 2015 May; 11(5):276-88. PubMed ID: 25732520
[TBL] [Abstract][Full Text] [Related]
13. Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes.
Higuchi C; Nakatsuka A; Eguchi J; Teshigawara S; Kanzaki M; Katayama A; Yamaguchi S; Takahashi N; Murakami K; Ogawa D; Sasaki S; Makino H; Wada J
Metabolism; 2015 Apr; 64(4):489-97. PubMed ID: 25726255
[TBL] [Abstract][Full Text] [Related]
14. Taxol-induced unfolded protein response activation in breast cancer cells exposed to hypoxia: ATF4 activation regulates autophagy and inhibits apoptosis.
Notte A; Rebucci M; Fransolet M; Roegiers E; Genin M; Tellier C; Watillon K; Fattaccioli A; Arnould T; Michiels C
Int J Biochem Cell Biol; 2015 May; 62():1-14. PubMed ID: 25724736
[TBL] [Abstract][Full Text] [Related]
15. Brown adipose tissue activity as a target for the treatment of obesity/insulin resistance.
Poher AL; Altirriba J; Veyrat-Durebex C; Rohner-Jeanrenaud F
Front Physiol; 2015; 6():4. PubMed ID: 25688211
[TBL] [Abstract][Full Text] [Related]
16. Profiling peripheral microRNAs in obesity and type 2 diabetes mellitus.
Wu L; Dai X; Zhan J; Zhang Y; Zhang H; Zhang H; Zeng S; Xi W
APMIS; 2015 Jul; 123(7):580-5. PubMed ID: 25912229
[TBL] [Abstract][Full Text] [Related]
17. Endogenous and microbial biomarkers for periodontitis and type 2 diabetes mellitus.
Li S; Li H; Kong H; Wu SY; Cheng CK; Xu J
Front Endocrinol (Lausanne); 2023; 14():1292596. PubMed ID: 38149100
[TBL] [Abstract][Full Text] [Related]
18. Recent advances of long non-coding RNAs in control of hepatic gluconeogenesis.
Wang Z; Ma J; Wu R; Kong Y; Sun C
Front Endocrinol (Lausanne); 2023; 14():1167592. PubMed ID: 37065737
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs-mediated regulation pathways in rheumatic diseases.
Assadiasl S; Rajabinejad M; Soleimanifar N; Makiyan F; Azizi E; Rezaiemanesh A; Nicknam MH
Inflammopharmacology; 2023 Feb; 31(1):129-144. PubMed ID: 36469219
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNA Related to Cardiometabolic Risk Factors for Metabolic Syndrome: A Systematic Review.
Brandão-Lima PN; Carvalho GB; Payolla TB; Sarti FM; Rogero MM
Metabolites; 2022 Oct; 12(11):. PubMed ID: 36355127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
